Literature DB >> 16872298

Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients.

Gustavo Wissmann1, Míriam J Alvarez-Martinez, Steven R Meshnick, Ada R S Dihel, João C Prolla.   

Abstract

Several studies from developed countries have documented the association between trimethoprim-sulfamethoxazole prophylaxis failure and mutations in the Pneumocystis jirovecii gene coding for dihydropteroate synthase (DHPS). DNA was extracted from Giemsa-stained smears of 70 patients with P. jirovecii pneumonia seen in Porto Alegre, Brazil, from 1997 to 2004. Successful PCR amplification of the DHPS locus was obtained in 57 of 70 cases (81.4%), including five cases (8.7%) that had used sulfa prophylaxis. No DHPS gene mutations were seen. These results suggest that DHPS mutations are currently as rare in Brazil as in other developing countries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872298     DOI: 10.1111/j.1550-7408.2006.00104.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  9 in total

1.  High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.

Authors:  Leigh Dini; Mignon du Plessis; John Frean; Victor Fernandez
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

2.  Pneumocystis jirovecii infection and the associated dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR) mutations in HIV-positive individuals from Pune, India.

Authors:  Arati Mane; Pankaj Gujar; Jipsi Chandra; Rahul Lokhande; Tilak Dhamgaye; Shivhari Ghorpade; Arun Risbud
Journal:  Mycopathologia       Date:  2014-09-30       Impact factor: 2.574

3.  Mutational analysis of Pneumocystis jirovecii dihydropteroate synthase and dihydrofolate reductase genes in HIV-infected patients in China.

Authors:  Xilong Deng; Li Zhuo; Yun Lan; Zhaoxia Dai; Wan-shan Chen; Weiping Cai; Joseph A Kovacs; Liang Ma; Xiaoping Tang
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

4.  High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.

Authors:  Carolina A Ponce; Magali Chabé; Claudio George; Alejandra Cárdenas; Luisa Durán; Julia Guerrero; Rebeca Bustamante; Olga Matos; Laurence Huang; Robert F Miller; Sergio L Vargas
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

5.  Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey.

Authors:  Soykan Ozkoc; Ceren Erguden; Songul Bayram Delibas
Journal:  Parasitol Res       Date:  2018-07-19       Impact factor: 2.289

6.  Genetic diversity of Pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: Cross-sectional study.

Authors:  Giannina Ricci; Daniel Wagner Santos; Joseph A Kovacs; Angela Satie Nishikaku; Taina Veras de Sandes-Freitas; Anderson Messias Rodrigues; Geetha Kutty; Regina Affonso; Hélio Tedesco Silva; José Osmar Medina-Pestana; Marcello Fabiano de Franco; Arnaldo Lopes Colombo
Journal:  Mycoses       Date:  2018-07-27       Impact factor: 4.377

Review 7.  Clinical and translational research in pneumocystis and pneumocystis pneumonia.

Authors:  L Huang
Journal:  Parasite       Date:  2011-02       Impact factor: 3.000

Review 8.  Pneumocystis jirovecii pneumonia in developing countries.

Authors:  Y de Armas Rodríguez; G Wissmann; A L Müller; M A Pederiva; M C Brum; R L Brackmann; V Capó de Paz; E J Calderón
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

Review 9.  Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review.

Authors:  Pierre Bonnet; Solène Le Gal; Enrique Calderon; Laurence Delhaes; Dorothée Quinio; Florence Robert-Gangneux; Sophie Ramel; Gilles Nevez
Journal:  Front Cell Infect Microbiol       Date:  2020-09-29       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.